medigraphic.com
ISSN 1561-3070 (Electronic)

2021, Number 4

<< Back Next >>

Rev Cub Oftal 2021; 34 (4)

Cytomegalovirus endotheliitis and its diagnosis by confocal microscopy

Noriega MJL, Castillo PAC, Méndez DAM, Benítez MMC, Cabrera CN

Language: Spanish
References: 15
Page: 1-16
PDF size: 425.29 Kb.


ABSTRACT

Objective: Describe the characteristics of the corneal endothelium by confocal microscopy in patients with inclusion basophilic lesions as pathognomonic signs of cytomegalovirus endotheliitis.
Methods: An observational study was conducted of clinical cases of patients diagnosed with cytomegalovirus endotheliitis attending the Cornea Service at Ramón Pando Ferrer Cuban Institute of Ophthalmology from February 2010 to June 2018. The study sample was 39 patients with a clinical diagnosis of endotheliitis who underwent confocal microscopy with a Confoscan 4 device (Nidek Technologies).
Results: Of the 39 patients examined, 29 were male and 10 were female. All were aged 41-60 years. 97.4% had a history of viral conjunctivitis and only one was HIV positive (2.6%). Best corrected visual acuity was 0.3 or less in 100% before treatment, and 0.8 to 1.0 after treatment. Inclusion basophilic bodies visible by confocal microscopy were observed in the corneal endothelium of all patients.
Conclusions: A relationship exists between the presence of inclusion basophilic bodies in the corneal endothelium and virological tests positive for cytomegalovirus, making it possible to perform PCR testing in cases with confocal microscopy confirmation of the pathognomonic characteristics of the corneal endothelium.


REFERENCES

  1. Kanski JJ. Oftalmología Clínica. Ámsterdam. ELSEVIER; 2017 [acceso: 12/10/2021];6:168. Disponible en: https://www.elsevier.com/books/kanski-oftalmologia-clinica/salmon/978-84-9113-893-8

  2. Luck S, Wieringa J, Blázquez D, Henneke P, Schuster K, Butler K, et al. Congenital cytomegalovirus: a European Expert Consensus Statement on Diagnosis and Management. Pediatr Infect Dis J. 2017;36(12):1205-13. DOI: https://doi.org/10.1097/INF.0000000000001763

  3. Crumpacker CS, Wadhwa S. Cytomegalovirus. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. Philadelphia, Pa: Elsevier Churchill Livingstone; 2005:134.

  4. Permar S, Schleiss M, Plotkin S. Advancing our understanding of protective maternal immunity as a guide for development of vaccines to reduce congenital cytomegalovirus infections. J Virol. 2018;92(7). DOI: https://doi.org/10.1128/JVI.00030-18

  5. Schleiss M, Permar S, Plotkin S. Progress toward Development of a Vaccine against Congenital Cytomegalovirus Infection. Clin Vaccine Immunol. 2017;24(12). DOI: https://doi.org/10.1128/CVI.00268-17

  6. Ronchi A, Shimamura M, Malhotra P, Sánchez P. Encouraging postnatal cytomegalovirus (CMV) screening: the time is NOW for universal screening! Expert Rev Anti Infect Ther. 2017;15(5):417-9. DOI: https://doi.org/10.1080/14787210.2017.1303377

  7. Castillo A, Benítez MC, Gómez Z, Rodríguez S. Microscopia Confocal. En: Río Torres M, Capote A, Hernández JR, Eguías F, Padilla C. Oftalmología. Criterios y tendencias actuales. La Habana: Editorial Ciencias Médicas; 2009. p. 89-109.

  8. Koizumi N, Suzuki T, Uno T, et al. Cytomegalovirus as an etiologic factor in corneal endotheliitis. Ophthalmology. 2008;115(2):292-7. DOI: https://doi.org/10.1016/j.ophtha.2007.04.053

  9. Smet M. Cytomegalovirus and the Eye. En: Pleyer U, Mondino B. Uveitis and immunological Disorder. Springer; 2005. p. 161-71.

  10. Pasternak Y, Ziv L, Attias J, Amir J, Bilavsky E. Valganciclovir is beneficial in children with congenital cytomegalovirus and isolated hearing loss. J Pediatr. 2018;199:166-70. DOI: https://doi.org/10.1016/j.jpeds.2018.02.028

  11. Kimberlin D, Jester P, Sánchez P, Ahmed A, Arav-Boger R, Michaels M, et al. Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med. 2015;372(10):933-43. DOI: https://doi.org/10.1056/NEJMoa1404599

  12. Yamauchi Y, Suzuki J, Sakai J, Sakamoto S, Iwasaki T, Usui M. A case of hypertensive keratouveitis with endotheliitis associated with cytomegalovirus. Ocul Immunol Inflamm. 2007;15(5):399-401. DOI: https://doi.org/10.1080/09273940701486795

  13. Suzuki T, Hara Y, Uno T, Ohashi Y. DNA of cytomegalovirus detected by PCR in aqueous of patient with corneal endothelitis after penetrating keratoplasty. Cornea. 2007;26(3):370-2. DOI: https://doi.org/10.1097/ICO.0b013e31802d82fa

  14. Gantt S, Dionne F, Kozak F, Goshen O, Goldfarb D, Park A, et al. Cost-effectiveness of universal and targeted new- born screening for congenital cytomegalovirus infection. JAMA Pediatr. 2016;170(12):1173-80. DOI: https://doi.org/10.1001/jamapediatrics.2016.2016

  15. Rawlinson W, Boppana S, Fowler K, Kimberlin D, Laz-zarotto T, Alain S, et al. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infec Dis. 2017;17(6):e177-e88. DOI: https://doi.org/10.1016/S1473-3099(17)30143-3




2020     |     www.medigraphic.com